Frontiers in Pharmacology (Oct 2024)

Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

  • Cataldo Martucci,
  • Andrew Dennis Allen,
  • Nadia Moretto,
  • Valentina Bagnacani,
  • Alessandro Fioni,
  • Riccardo Patacchini,
  • Maurizio Civelli,
  • Gino Villetti,
  • Fabrizio Facchinetti

DOI
https://doi.org/10.3389/fphar.2024.1497520
Journal volume & issue
Vol. 15

Abstract

Read online

No abstracts available.

Keywords